VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BRNSBarinthus Biotherapeutics plc
$0.70$29M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBRNSPrice History

BRNS logoBarinthus Biotherapeutics plc (BRNS) Stock Price History

Historical prices from 2021 to 2026

$0.70+0.04  (+5.39%)close Jun 22
Returns
1M
+3.7%
3M
+3.6%
YTD
-9.9%
1Y
-23.9%
3Y
-33.6%
5Y
-45.9%
ATH$17.99Jun 2021-96.1%
ATL$0.51Mar 2026pre-split
Avg Vol (50D)22K/ day
52-Week Range$0.51 — $2.92
LowCurrent: $0.70High

Loading 10-year price history...

BRNS Historical Performance

1 YearTotal Return
-23.9%
Price: -23.9%
3 YearsTotal Return
-70.7%
CAGR: -33.6%
Price: -70.7%
5 YearsTotal Return
-95.4%
CAGR: -45.9%
Price: -95.4%
YTD
-9.9%

BRNS Annual Returns

Year-by-year price performance · 2021–2026

Best+53.8%2023
Worst-78.9%2022
Up years1/6
2021-21.2%
2022-78.9%
2023+53.8%
2024-67.3%
2025-43.5%
2026-20.5%
2021 annual price return
-21.2%
2022 annual price return
-78.9%
2023 annual price return
+53.8%
2024 annual price return
-67.3%
2025 annual price return
-43.5%
2026 annual price return
-20.5%
LessMore
Alpha vs S&P 500
1Y-48.9%
3Y-51.9%
5Y-57.5%

Price returns only.

Download Historical Data

1,292 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

BRNS Stock Price Trajectory (2021–2026)

As of June 22, 2026, Barinthus Biotherapeutics plc (BRNS) trades at $0.70, representing a -23.9% return over the past year. The stock has delivered a -95.4% total return over five years (-45.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $17.99 on June 30, 2021. From this peak, BRNS has corrected -96.1%, currently trading 14% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers IMVT (+122.8% 1Y), NKTX (+57.1% 1Y), and IMCR (-9.8% 1Y), BRNS has underperformed the peer group average. Compare BRNS vs IMVT →

BRNS Historical Price Data · from 2021

Rows 1–50 of 1,292
Date Open High Low Close Volume Change %
2026-06-220.770.770.670.7031K+5.39%
2026-06-180.700.700.660.6610K-5.20%
2026-06-170.670.700.670.7010K-0.13%
2026-06-160.680.700.680.7073K-0.16%
2026-06-150.690.740.670.702K+4.38%
2026-06-120.680.720.670.6749K-7.31%
2026-06-110.700.740.690.7218K+4.37%
2026-06-100.680.690.650.6922K-4.20%
2026-06-090.740.740.640.72102K+9.70%
2026-06-080.650.700.640.6643K+1.21%
2026-06-050.670.700.650.653K-4.10%
2026-06-040.670.700.660.68273+3.03%
2026-06-030.660.700.650.664K0.00%
2026-06-020.700.700.660.663K-3.04%
2026-06-010.680.700.680.681K0.00%
2026-05-290.660.680.660.682K+4.56%
2026-05-280.640.700.640.653K-6.97%
2026-05-270.710.710.680.704K+2.69%
2026-05-260.700.700.640.6820K-0.80%
2026-05-220.710.720.670.698K-1.98%
2026-05-210.690.710.680.7012K+2.02%
2026-05-200.700.710.640.6951K+3.93%
2026-05-190.660.720.660.6619K+3.52%
2026-05-180.700.700.630.6473K-1.78%
2026-05-150.690.690.640.6510K-8.57%
2026-05-140.700.710.650.7135K+4.54%
2026-05-130.720.730.680.6812K-2.84%
2026-05-120.720.720.660.7013K+2.19%
2026-05-110.710.710.670.6950K+2.24%
2026-05-080.700.700.650.6719K0.00%
2026-05-070.660.680.660.6711K+5.51%
2026-05-060.660.700.630.6440K-3.05%
2026-05-050.640.680.630.6617K+3.15%
2026-05-040.630.670.630.648K-2.41%
2026-05-010.630.670.630.656K+0.11%
2026-04-300.610.650.610.6528K+8.35%
2026-04-290.610.630.590.6011K-1.66%
2026-04-280.640.650.610.6111K-3.17%
2026-04-270.630.640.590.6314K-1.87%
2026-04-240.680.680.600.648K+0.47%
2026-04-230.660.680.610.6425K+2.21%
2026-04-220.610.680.600.6331K+5.97%
2026-04-210.590.620.590.5920K0.00%
2026-04-200.620.620.590.5936K0.00%
2026-04-170.590.620.590.5915K-0.17%
2026-04-160.610.610.590.5916K-0.34%
2026-04-150.590.640.590.5911K+2.76%
2026-04-140.590.620.550.5835K+4.93%
2026-04-130.580.600.550.5528K-3.08%
2026-04-100.600.600.550.5720K+3.18%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BRNS — Frequently Asked Questions

Quick answers to the most common questions about buying BRNS stock.

How has BRNS stock performed recently?

BRNS declined -23.9% over the past year, below its 5-year annualized CAGR of -45.9%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is BRNS's all-time high price?

Barinthus Biotherapeutics plc reached $17.99 on 2021-06-30. The 52-week high is $2.92. Current 1-year return of -23.9% places the stock further from historical peaks.

Where can I download BRNS historical price data?

This page provides BRNS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

432 data points · sampled from 1,292